Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
19.64
-0.98 (-4.75%)
At close: Jun 2, 2026, 4:00 PM EDT
19.77
+0.13 (0.66%)
After-hours: Jun 2, 2026, 4:26 PM EDT
Bicara Therapeutics Employees
Bicara Therapeutics had 103 employees as of December 31, 2025. The number of employees increased by 48 or 87.27% compared to the previous year.
Employees
103
Change (1Y)
48
Growth (1Y)
87.27%
Revenue / Employee
n/a
Profits / Employee
-$1,527,330
Market Cap
1.29B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | 48 | 87.27% |
| Dec 31, 2024 | 55 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 711 |
| Ardelyx | 489 |
| Maravai LifeSciences Holdings | 416 |
| UroGen Pharma | 298 |
| Maze Therapeutics | 141 |
| MapLight Therapeutics | 133 |
| MoonLake Immunotherapeutics | 130 |
| Septerna | 130 |
BCAX News
- 11 days ago - Bicara Therapeutics Transcript: Study update - Transcripts
- 11 days ago - Bicara Therapeutics Press release: Study update - Filings
- 11 days ago - Bicara Therapeutics Slides: Study update - Filings
- 12 days ago - Bicara Therapeutics management to meet with Cantor - TheFly
- 12 days ago - Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC - GlobeNewsWire
- 20 days ago - Bicara Therapeutics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 20 days ago - Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 21 days ago - Bicara Therapeutics price target raised to $37 from $36 at Morgan Stanley - TheFly